Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club

Antegrade dissection reentry with Stingray device (Boston Scientific, Marlborough, MA) accounts for 20–34% of the chronic total occlusion (CTO) cases in the various hybrid operators' CTO registries and is an important component of CTO crossing algorithms. The Stingray device can facilitate ante...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Catheter Cardiovasc Interv
Main Authors: Wu, Eugene B., Brilakis, Emmanouil S., Lo, Sidney, Kalyanasundaram, Arun, Mashayekhi, Kambis, Kao, Hsien‐Li, Lim, Soo‐Teik, Ge, Lei, Chen, Ji‐Yan, Qian, Jie, Lee, Seung‐Whan, Harding, Scott A., Tsuchikane, Etsuo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Coronary Artery Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754104/
https://ncbi.nlm.nih.gov/pubmed/31769597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccd.28607
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados